US authorizing the use of anti-viral drug Remdesivir for treating coronavirus

According to US tabloids, US’s Food and Drug Administration (FDA) gave its approval on emergency use of the Ebola drug remdesivir for treating the coronavirus.

Thus, people who are hospitalised with severe Covid-19 will be administered with anti-viral drug produced by Gilead pharmaceutical company in.

A recent clinical trial showed positive results. The reports showed that the drug helped shorten the recovery time for people who were seriously ill but no improvement concerning the survival rates have been noticed.

The drug interferes with the virus’s genome, disrupting its ability to replicate, however, experts warned that this drug should not be seen as a “magic bullet” for coronavirus.

During a meeting with US President Donald Trump, Gilead Chief Executive Daniel O’Day said the FDA authorization was an important first step. According to him, the company would contribute 1.5 million vials of the drug.

“It’s the first authorized therapy for Covid-19, so we’re really proud to be part of it.” Explained FDA Commissioner Stephen Hahn.

Note that Emergency FDA authorization is not the same as formal approval.


Leave a Comment